{"id":1738,"date":"2026-07-28T13:53:00","date_gmt":"2026-07-28T12:53:00","guid":{"rendered":"https:\/\/services.nhslothian.scot\/neuroprogressiveanddementianetwork\/?page_id=1738"},"modified":"2026-07-28T13:59:11","modified_gmt":"2026-07-28T12:59:11","slug":"imarkhd","status":"publish","type":"page","link":"https:\/\/services.nhslothian.scot\/neuroprogressiveanddementianetwork\/imarkhd\/","title":{"rendered":"iMarkHD"},"content":{"rendered":"\n
<\/div>
<\/div><\/div>
\n

Investigating biomarkers for disease and symptom progression in Huntington\u2019s disease<\/h1>\n\n\n\n

iMarkHD: In Vivo Longitudinal Imaging of Huntington\u2019s disease Pathology<\/h3>\n<\/div><\/div><\/div><\/div><\/div>\n\n\n\n
\n
\"CHDI<\/figure>
\n

Project Details<\/strong><\/p>\n\n\n\n

Start Date
July 2022<\/strong><\/p>\n\n\n\n

Status
Open to Recruitment<\/strong><\/p>\n\n\n\n

Principal Investigator
Dr Peter Foley<\/a><\/p>\n\n\n\n

NDN Study Lead
Jacqueline Kerr<\/a><\/p>\n\n\n\n

Main Research Site
King’s College London<\/strong><\/p>\n<\/div><\/div>\n\n\n\n

The NDN and NHS Lothian Huntington’s service, are helping to identify people who may be interested in taking part in the iMarkHD study. <\/strong>

This research study is trying to better understand the changes in the brain that happen when a person has Huntington\u2019s disease<\/strong>.<\/p>\n\n\n\n

This study is based at King’s College London<\/u><\/strong><\/u><\/strong>.<\/h4>\n\n\n\n

<\/p>\n\n\n\n

What Happens In This Study?<\/strong><\/p>\n\n\n\n

You will have two types of imaging scans; one called Positron Emission Tomography (PET) and another called Magnetic Resonance Imaging (MRI), as well as taking part in several physical and cognitive assessments, and blood tests.<\/p>\n\n\n\n

Can I Join This Study?<\/strong><\/p>\n\n\n\n

To take part in this research study, you must also meet these 4 requirements<\/strong>:<\/p>\n\n\n\n

    \n
  1. Your Diagnosis:<\/strong> Both people with and without<\/strong>, either a diagnosis of Huntington\u2019s disease<\/strong><\/strong> OR carrying the Huntington\u2019s disease<\/strong><\/strong> gene mutation<\/strong>, can take part. <\/li>\n\n\n\n
  2. Your Age:<\/strong> You are between 21 and 75 years old<\/strong>.<\/li>\n\n\n\n
  3. Your Permission:<\/strong> You must be able to understand what happens in the study and sign a form (called informed consent<\/strong>) to say you agree to join.<\/li>\n\n\n\n
  4. Your Time:<\/strong> This study is based at King’s College London.<\/strong> You must do your best to attend all your study visits, and follow the rules of the study until it ends.<\/li>\n<\/ol>\n\n\n\n

    Study Length<\/strong>: 3 years<\/p>\n\n\n\n

    Number of appointments<\/strong>: 10 visits<\/p>\n\n\n\n

    More information on the trial can be found by contacting us at loth.sdcrn@nhs.scot<\/a> or by calling 0131 537 3804<\/strong>.<\/p>\n<\/div><\/div>\n\n\n\n